Journal
BLOOD
Volume 104, Issue 12, Pages 3437-3444Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2004-06-2234
Keywords
-
Categories
Funding
- NCI NIH HHS [CA80188] Funding Source: Medline
Ask authors/readers for more resources
In most myeloid leukemias induced in mice by gamma-racliation, one copy of chromosome 2 has suffered a deletion. To search for a potential tumor suppressor gene in that region, we have delineated the deletions in a panel of these tumors. A commonly deleted region of 2 megabase pairs (Mbp) includes the gene encoding the PUA transcription factor, a powerful inducer of g ran u locytic/monocytic differentiation. Significantly, in 87% of these tumors the remaining PUA allele exhibited point mutations in the PUA DNA binding domain. Surprisingly, 86% of these mutations altered a single CpG, implicating deamination of deoxycytidine, a common mutational mechanism, as the origin of this lesion. The hot spot resides in the codon for a Contact residue essential for DNA binding by PU.1.. In keeping with a tumor suppressor role for PU.1, enforced expression of wild-type PU.1 in the promyelocytic leukemia cells inhibited their clonogenic growth, induced monocytic differentiation, and elicited apoptosis. The mutant PU.1. found in tumors retained only minimal growth suppressive function. The results suggest that PU.1 normally suppresses development of myeloid leukemia by promoting differentiation and that the combination of gene deletion and a point mutation that impairs its ability to bind DNA is particularly leukemogenic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available